Conor McNamara
Stock Analyst at RBC Capital
(1.78)
# 1,378
Out of 4,650 analysts
94
Total ratings
30.99%
Success rate
-9.73%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher | Maintains: Outperform | $767 → $718 | $552.54 | +29.95% | 13 | Oct 24, 2024 | |
| DHR Danaher | Maintains: Outperform | $333 → $311 | $244.12 | +27.40% | 7 | Oct 23, 2024 | |
| ILMN Illumina | Reiterates: Outperform | $252 | $144.03 | +74.96% | 11 | Oct 10, 2024 | |
| RGEN Repligen | Reiterates: Outperform | $205 | $137.21 | +49.41% | 9 | Sep 26, 2024 | |
| AVTR Avantor | Reiterates: Outperform | $34 | $22.64 | +50.18% | 5 | Sep 26, 2024 | |
| QDEL QuidelOrtho | Reiterates: Outperform | $61 | $38.73 | +57.50% | 10 | Aug 16, 2024 | |
| HOLX Hologic | Reiterates: Sector Perform | $82 | $80.46 | +1.91% | 7 | Aug 16, 2024 | |
| MRVI Maravai LifeSciences Holdings | Reiterates: Outperform | $15 | $7.21 | +108.04% | 5 | Aug 16, 2024 | |
| OABI OmniAb | Reiterates: Outperform | $7 | $3.87 | +80.88% | 2 | Aug 16, 2024 | |
| BIO Bio-Rad Laboratories | Reiterates: Outperform | $401 | $328.59 | +22.04% | 7 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $401 | $334.85 | +19.76% | 7 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $72 → $70 | $70.38 | -0.54% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $3.57 | +96.08% | 4 | Aug 7, 2024 |
Thermo Fisher
Oct 24, 2024
Maintains: Outperform
Price Target: $767 → $718
Current: $552.54
Upside: +29.95%
Danaher
Oct 23, 2024
Maintains: Outperform
Price Target: $333 → $311
Current: $244.12
Upside: +27.40%
Illumina
Oct 10, 2024
Reiterates: Outperform
Price Target: $252
Current: $144.03
Upside: +74.96%
Repligen
Sep 26, 2024
Reiterates: Outperform
Price Target: $205
Current: $137.21
Upside: +49.41%
Avantor
Sep 26, 2024
Reiterates: Outperform
Price Target: $34
Current: $22.64
Upside: +50.18%
QuidelOrtho
Aug 16, 2024
Reiterates: Outperform
Price Target: $61
Current: $38.73
Upside: +57.50%
Hologic
Aug 16, 2024
Reiterates: Sector Perform
Price Target: $82
Current: $80.46
Upside: +1.91%
Maravai LifeSciences Holdings
Aug 16, 2024
Reiterates: Outperform
Price Target: $15
Current: $7.21
Upside: +108.04%
OmniAb
Aug 16, 2024
Reiterates: Outperform
Price Target: $7
Current: $3.87
Upside: +80.88%
Bio-Rad Laboratories
Aug 16, 2024
Reiterates: Outperform
Price Target: $401
Current: $328.59
Upside: +22.04%
Aug 16, 2024
Reiterates: Outperform
Price Target: $401
Current: $334.85
Upside: +19.76%
Aug 8, 2024
Maintains: Sector Perform
Price Target: $72 → $70
Current: $70.38
Upside: -0.54%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $3.57
Upside: +96.08%